Rifampin Capsule · #17 of 35 active shortages by FDA posting duration
Brand: RIFAMPIN
FDA lists Rifampin Capsule as Active Shortage (Epic Pharma, LLC).
Availability on file: Unavailable
Rifampin Capsule: Active Shortage
Unavailable 12 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Rifampin Capsule
- Manufacturer
- Epic Pharma, LLC
- Dosage Form
- Capsule
- Presentation
- Rifampin, Capsule, 150 mg (NDC 42806-801-01)
- Package NDC
- 42806-801-01
Status & Timeline
- Status
- Active Shortage
- Availability
- Unavailable
- First Reported
- Dec 22, 2021
- Last Updated
- Mar 5, 2026
- Therapeutic Category
- Anti-Infective
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Discontinuation of the manufacture of the drug.
Full Drug Profile
rifampin
Side effects, interactions, warnings & more
Nearby, Other Rifampin Shortage Records
Rifampin Injection
Sanofi-Aventis U.S. LLC
Injection
Rifampin Injection
Mylan Institutional, a Viatris Company
Injection
Rifampin Injection
Fresenius Kabi USA, LLC
Injection
Rifampin Capsule
Epic Pharma, LLC
Capsule
Rifampin Capsule
Epic Pharma, LLC
Capsule
Rifampin Capsule
Epic Pharma, LLC
Capsule
FDA reason on file: Discontinuation of the manufacture of the drug. General shortage guidance lives on the tracker hub.